Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns

Key Takeaways Insulet shares tumbled Friday after the maker of insulin management devices suggested new user growth could be lower than previously expected in the second half of 2024. Strong sales of its Omnipod device helped Insulet top second-quarter revenue expectations. The company raised its guidance for full-year revenue growth. Shares of Insulet (PODD) suffered the heaviest losses of any S&P 500 stock on Friday, dropping 8.8% after the maker of insulin management devices suggested new user growth cou ...